a-1 (female)

Sample type: Plasma
Optimal result: 45 – 100 mg/dL

Low a-1 level is a significant predictor of recurrent CVD events.

Low levels of α-1 HDL, as measured by the Boston Heart HDL Map test, signify a higher risk of recurrent cardiovascular disease (CVD) events. This marker is crucial because α-1 HDL is the most effective type of HDL in removing cholesterol from the bloodstream. When levels are low, it indicates that the body is less capable of clearing out cholesterol, leading to a buildup that can cause heart problems. Diagnosing low α-1 HDL involves a simple blood test, but understanding the causes is more complex. Low levels can result from factors like poor diet, lack of exercise, smoking, obesity, and genetic predispositions. Symptoms of low α-1 HDL might not be obvious until significant cardiovascular issues arise, such as chest pain, shortness of breath, or even heart attacks. To address low α-1 HDL, lifestyle modifications are often recommended, such as eating a diet low in saturated fats and cholesterol, reducing sugar intake, exercising regularly, quitting smoking, and losing weight if necessary. In some cases, medications may be prescribed to help increase HDL levels. These interventions aim to improve overall heart health and reduce the risk of future cardiovascular events. By focusing on increasing α-1 HDL levels, patients can better manage their heart health and lower their chances of serious complications.

Lifestyle modification (if indicated)

  • Low saturated fat (<7%)
    • Low cholesterol (<200 mg/day)
    • Low sugar
    • Exercise >30 minutes per day
  • Smoking cessation
  • Weight reduction (if indicated)
  • Medications and their impact on HDL Particles

Low a-1 level is a significant predictor of recurrent CVD events.

The marker α-1 from the Boston Heart HDL Map test is a key player in understanding cardiovascular health. HDL, or high-density lipoprotein, often called "good cholesterol," helps carry cholesterol away from the arteries to the liver, where it can be removed from the body. Among the different types of HDL, α-1 is the most mature and efficient at clearing cholesterol from the bloodstream. When levels of α-1 HDL are low, it’s a red flag because it significantly increases the risk of recurring heart problems.

Low a-1 level is a significant predictor of recurrent CVD events.

The marker α-1 from the Boston Heart HDL Map test is a key player in understanding cardiovascular health. HDL, or high-density lipoprotein, often called "good cholesterol," helps carry cholesterol away from the arteries to the liver, where it can be removed from the body. Among the different types of HDL, α-1 is the most mature and efficient at clearing cholesterol from the bloodstream. When levels of α-1 HDL are low, it’s a red flag because it significantly increases the risk of recurring heart problems. Studies have shown that low α-1 HDL levels are one of the strongest predictors of future cardiovascular issues, even more so than some other well-known risk factors. This means that patients with low α-1 HDL need to be watched closely and might need to make lifestyle changes or take medications to boost their α-1 HDL levels and lower their risk of heart disease. This marker gives doctors crucial information to make better decisions about a patient's treatment and preventive care. By focusing on α-1 HDL levels, healthcare providers can more effectively manage and reduce the risk of heart attacks and other cardiovascular events in their patients.

a-1 (female)
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond a-1 (female) — 10,000+ markers explained
One a-1 (female) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro